The US Food and Drug Administration (FDA) has granted Rare Paediatric Disease Designation to Orchard Therapeutics’ metachromatic leukodystrophy (MLD) gene...
Read More...
The post Orchard gene therapy candidate receives Rare Paediatric Disease Designation appeared first on Drug Development Technology.